Pathophysiology Of Retina In Type Ii Diabetes Mellitus Conventional Diagnostic Parameters Versus Emerging Roles Of Growth Factors And Cytokines

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• PREVALENCE OF DIABETIC RETINOPATHY IN TYPE II DIABETES IN RELATION TO RISK FACTORS: A HOSPITAL BASED STUDY

  2014cited by this paper
• Pathophysiology of Diabetic Retinopathy

  2013cited by this paper
• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I

  2013cited by this paper
• Retinal vascular calibre as a predictor of incidence and progression of diabetic retinopathy

  2012cited by this paper
• Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

  2012cited by this paper
• Panretinal photocoagulation for diabetic retinopathy.

  2012cited by this paper
• Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening

  2012cited by this paper
• The role of oxidative stress and antioxidants in diabetic complications.

  2012cited by this paper
• Global Prevalence and Major Risk Factors of Diabetic Retinopathy

  2012cited by this paper
• Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

  2012cited by this paper
• Screening for presence or absence of diabetic retinopathy: a meta-analysis.

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Frequency and Types of Diabetic Retinopathy in Type II Diabetes;A Hospital Base Study -

  2011cited by this paper
• Vitreous Vascular Endothelial Growth Factor Concentrations in Proliferative Diabetic Retinopathy versus Proliferative Vitreoretinopathy

  2011cited by this paper
• Cell-Based Therapies for Diabetic Retinopathy

  2011cited by this paper
• Inflammation and diabetic retinal microvascular complications

  2011cited by this paper
• Diabetic retinopathy - An update.

  2011cited by this paper
• Hemoglobin A1c and fasting plasma glucose levels as predictors of retinopathy at 10 years: the French DESIR study.

  2011cited by this paper
• Microvascular complications and risk factors in patients with type 2 diabetes.

  2011cited by this paper
• Antivascular endothelial growth factor in diabetic retinopathy.

  2010cited by this paper
• Epidemiology of diabetic retinopathy

  2010cited by this paper
• Microvascular Complications of Diabetes

  2010cited by this paper
• Prevalence of diabetic retinopathy in the United States, 2005-2008.

  2010cited by this paper
• A review of clinical trials of anti-VEGF agents for diabetic retinopathy

  2010cited by this paper
• Intravitreal bevacizumab for diabetic retinopathy.

  2009cited by this paper
• Ranibizumab for diabetic retinopathy.

  2009cited by this paper
• Metabolic control and diabetic retinopathy.

  2009cited by this paper
• 21st century endocrinology.

  2009cited by this paper
• Systemic management of diabetic retinopathy

  2009cited by this paper
• Pathophysiology of diabetic retinopathy and nephropathy

  2009cited by this paper
• Diabetic retinopathy and angiogenesis.

  2009cited by this paper
• Global diabetes landscape—type 2 diabetes mellitus in South Asia: Epidemiology, risk factors, and control

  2008cited by this paper
• Recent advances in the management of type 2 diabetes mellitus: a review

  2008cited by this paper
• Weight Change in Diabetes and Glycemic and Blood Pressure Control

  2008cited by this paper
• Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal

  2008cited by this paper
• Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes.

  2008cited by this paper
• The effects of growth factors on the proliferation and in vitro angiogenesis of human macular inner choroidal endothelial cells

  2008cited by this paper
• Microvascular and Macrovascular Complications of Diabetes

  2008cited by this paper
• Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients

  2008cited by this paper
• Ophthalmic treatment of diabetic retinopathy

  2008cited by this paper
• Benefits and limitations in vitreoretinal surgery for proliferative diabetic retinopathy and macular edema.

  2007cited by this paper
• Diabetic macular oedema: a clinical overview

  2007cited by this paper
• Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey

  2007cited by this paper
• Introducing anti-VEGF therapy in practice: A Danish perspective

  2007cited by this paper
• The Importance of Serum Lipids in Exudative Diabetic Macular Edema in Type 2 Diabetic Patients

  2007cited by this paper
• Regulation of angiogenesis: wound healing as a model.

  2007cited by this paper
• Arterial hypertension exacerbates oxidative stress in early diabetic retinopathy

  2007cited by this paper
• Screening for diabetic retinopathy: a comparative study between hospital and community based screening and between paying and non-paying patients.

  2007cited by this paper
• Pathophysiology of diabetic macular edema.

  2007cited by this paper
• Anti-vascular endothelial growth factor therapy for ocular neovascular disease

  2007cited by this paper
• Targeting the retinal microcirculation to treat diabetic sight problems

  2007cited by this paper
• Diabetic retinopathy: treatment and prevention

  2007cited by this paper
• Diabetic microvascular complications: can patients at risk be identified? A review

  2006cited by this paper
• DIABETIC RETINOPATHY: THE LATEST IN CURRENT MANAGEMENT

  2006cited by this paper
• Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy.

  2006cited by this paper
• Associations of Adiponectin Levels With Incident Impaired Glucose Metabolism and Type 2 Diabetes in Older Men and Women

  2006cited by this paper
• Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetic patients.

  2006cited by this paper
• Risk factors of diabetic retinopathy in type 2 diabetic patients

  2006cited by this paper
• Smoking and the ophthalmologist

  2006cited by this paper
• La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades

  2006cited by this paper
• Gene Expression of Leptin, Resistin, and Adiponectin in the White Adipose Tissue of Obese Patients with Non-Alcoholic Fatty Liver Disease and Insulin Resistance

  2006cited by this paper
• Prevalence of diabetic retinopathy among individuals screened positive for diabetes in five community-based eye camps in northern Karachi, Pakistan.

  2006cited by this paper
• Serum IL-1β, IL-2, and IL-6 in Insulin-Dependent Diabetic Children

  2006cited by this paper
• Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study

  2005cited by this paper
• Endothelial effects of leptin: Implications in health and diseases

  2005cited by this paper
• Angiogenic pathways in diabetic retinopathy.

  2005cited by this paper
• Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation.

  2005cited by this paper
• Role of cytokines and trophic factors in the pathogenesis of diabetic retinopathy.

  2005cited by this paper
• Endothelial/Pericyte Interactions

  2005cited by this paper
• Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

  2005cited by this paper
• Glycemic control, hypertension and chronic complications in type 2 diabetic subjects attending a tertiary care centre.

  2005cited by this paper
• Diabetic retinopathy: treating systemic conditions aggressively can save sight.

  2005cited by this paper
• Review article: diabetes, genetics and ethnicity

  2005cited by this paper
• THE IMPORTANCE OF ENDOTHELIAL DAMAGE: DIABETIC RETINOPATHY*

  2005cited by this paper
• CURRENT TRENDS IN DIABETIC RETINOPATHY

  2005cited by this paper
• STUDIES ON DIABETIC NEPHROPATHY AND SECONDARY DISEASES IN TYPE 2 DIABETES

  2005cited by this paper
• Retinopathy in Diabetic patients

  2005cited by this paper
• Retinopathy and microalbuminuria in type II diabetic patients

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Mice lacking insulin or insulin-like growth factor 1 receptors in vascular endothelial cells maintain normal blood-brain barrier.

  2004cited by this paper
• Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.

  2004cited by this paper
• Vascular endothelial growth factor: basic science and clinical progress.

  2004cited by this paper
• Diabetic retinopathy

  2004cited by this paper
• The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

  2004cited by this paper
• High Glucose Enhances Interleukin-6-induced Vascular Endothelial Growth Factor 165 Expression via Activation of Gp130-mediated p44/42 MAPK-CCAAT/Enhancer Binding Protein Signaling in Gingival Fibroblasts*

  2004cited by this paper
• The role of growth factors in the pathogenesis of diabetic retinopathy

  2004cited by this paper
• INTRAVITREOUS LEPTIN CONCENTRATIONS IN PATIENTS WITH PROLIFERATIVE DIABETIC RETINOPATHY

  2004cited by this paper
• The anti–angiogenic effects of opticin, a glycoprotein in the vitreous humour of the eye.

  2004cited by this paper
• New aspects in the pathogenesis of diabetic atherothrombosis.

  2004cited by this paper
• Prevalence of chronic complications and associated factors in type 2 diabetes.

  2004cited by this paper
• The prevalence of diabetic retinopathy among adults in the United States.

  2004cited by this paper
• Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.

  2004cited by this paper
• Epidemiology of diabetic retinopathy and macular oedema: a systematic review

  2004cited by this paper
• Incidence of diabetic retinopathy in the Barbados Eye Studies.

  2003cited by this paper
• Grading and disease management in national screening for diabetic retinopathy in England and Wales

  2003cited by this paper
• Medical treatment of diabetic retinopathy

  2003cited by this paper
• Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives

  2003cited by this paper
• Diabetic retinopathy: contemporary prevalence in a well-controlled population.

  2003cited by this paper
• Perspectives on diabetic retinopathy.

  2003cited by this paper
• Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.

  2003cited by this paper

• No citing papers are available for this paper.